Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 14 September 2021
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 14 September 2021. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Cont. of BXPHARMA): In the year ended 31 December 2020 (the last audited accounts prepared by Sanofi Bangladesh), Sanofi Bangladesh generated revenue of Taka 3.038 billion (approximately 25.8 million Pound), profit before tax of Taka 277.6 million (approximately 2.35 million Pound) and had gross assets of Taka 6.409 billion (approximately 54.4m Pound). A further announcement will be made in due course to confirm final completion of the Acquisition. (End)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace4e5a6b0000400527c8
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.